EMERGING PHARMACEUTICAL MARKETS
IMS Health used the term «emerging pharmaceutical markets» for the first time 5 years ago to describe the transition of rapid economic growth trend from economically mature to emerging countries such as China, Brazil, Russia, India, Mexico, Turkey and South Korea. In 2009 the overall market growth in the countries accounted for 37% of the total global pharmaceutical market growth, and is forecast to reach 48% by 2013.